Sera Prognostics (SERA) Cash from Financing Activities (2020 - 2026)
Sera Prognostics posted quarterly Cash from Financing Activities of $20000.0 for Q1 2026, down 99.96% year-on-year from $53.5 million in Q1 2025, and down 78.49% on a QoQ basis from $93000.0 in Q4 2025.
Sera Prognostics (SERA) has 7 years of Cash from Financing Activities data on file, last reported at $20000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 99.96% year-over-year to $20000.0; the trailing twelve-month figure through Mar 2026 stood at $504000.0 (down 99.09% YoY), and the FY2025 full-year result was $54.0 million, up 1970.76% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $20000.0, down from $93000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $53.5 million in Q1 2025 and bottomed at -$116000.0 in Q4 2022.
- The 5-year median for Cash from Financing Activities is $117000.0 (2024), against an average of $3.4 million.
- The widest annual swing landed in 2022, when Cash from Financing Activities sank 413.51%; it then surged 4979.89% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at -$116000.0 in 2022, then soared by 631.03% to $616000.0 in 2023, then tumbled by 62.01% to $234000.0 in 2024, then tumbled by 60.26% to $93000.0 in 2025, then sank by 78.49% to $20000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $20000.0 (Q1 2026), $93000.0 (Q4 2025), and $373000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Sera Prognostics | 30.02 Mn | 30.02 Mn | -28,000.00 | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 93,000.00 |
| Dec 31, 2025 | 93,000.00 |
| Sep 30, 2025 | 373,000.00 |
| Sep 30, 2025 | 373,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 53.54 Mn |
| Mar 31, 2025 | 53.54 Mn |
| Dec 31, 2024 | 234,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Jun 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | 616,000.00 |
| Dec 31, 2023 | 616,000.00 |
| Sep 30, 2023 | 128,000.00 |
| Sep 30, 2023 | 128,000.00 |
| Jun 30, 2023 | 124,000.00 |
| Jun 30, 2023 | 124,000.00 |
| Mar 31, 2023 | -116,000.00 |
| Mar 31, 2023 | -116,000.00 |
| Dec 31, 2022 | -116,000.00 |
| Dec 31, 2022 | -116,000.00 |
| Sep 30, 2022 | -8,000.00 |
| Sep 30, 2022 | -8,000.00 |
| Jun 30, 2022 | 58,000.00 |
| Jun 30, 2022 | 58,000.00 |
| Mar 31, 2022 | 71,000.00 |
| Mar 31, 2022 | 71,000.00 |
| Dec 31, 2021 | 37,000.00 |
| Dec 31, 2021 | 37,000.00 |
| Sep 30, 2021 | 68.93 Mn |
| Sep 30, 2021 | 68.93 Mn |
| Jun 30, 2021 | 37.16 Mn |
| Jun 30, 2021 | 37.16 Mn |
| Mar 31, 2021 | 53.47 Mn |
| Mar 31, 2021 | 53.47 Mn |
| Dec 31, 2020 | -920,000.00 |
| Dec 31, 2020 | -920,000.00 |
| Sep 30, 2020 | -938,000.00 |
| Sep 30, 2020 | -938,000.00 |